Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosis. - Ratsimandresy RA; Doran E; Dengler HS; Headland SE; Wedeles CJ; Guidi R; Xu D; Liu J; Shi Y; Wang J; Uttarwar S; Abbas AR; et al. (BioRxiv : the preprint server for biology, 2026)